… to be cost-effective, we assumed that PGx-guided treatment … testing strategy cost-effective
(odds ratio=0.13, P-value <0.05). … for 5 of the 10 drugs covered in this review. Similarly, the cost …

… regarding the validity of cost-effective ratios and QALYs may … compensation for the medicines
used to treat Pompe disease … Given the high price of this drug, this example demonstrates …

… [1;47;48] Though the prices of these drugs were much lower than current new drug price …
drugs as not cost-effective.[148;151] Also, the evidence for the effectiveness of orphan drugs is …

… PGx-guided treatment for the drugs clopidogrel and warfarin … PGx-guided clopidogrel
treatment was cost-effective in the … , this study did not specifically examine economic value, but …

… to treatment with a number of common drugs. … review has identified tests that are cost effective,
but analyses should be updated and revisited as the evidence base matures and the price …

… The evidence of how restrictive drug policies or increasing out… annual net price of $58,608
to be considered cost-effective. … drugs, and specifically DMTs, are the single largest medical …

… Whilst we cannot provide evidence of indications that are not being developed … drugs not
being cost-effective even at zero price, eg when used in combination with other costly therapies …

… was cost-effective only when targeted to specific severe subgroups or given considerable
price … Eight were funded by the manufacturer of omalizumab (Novartis Pharmaceuticals Corp.), …

… when a class of drugs becomes available without prescription… improved access to cost-effective
treatment without the need … in this review show that the availability of self-care medicines …

… drugs and procedures (Table 1). For example, ICER calculated lifetime cost estimates or
incremental cost-effective … medical care purchases. These additional elements, we would argue, …